Am J Transplant, Volume 16, Suppl 3 Archives - Page 45 of 180 - ATC Abstracts

2016 American Transplant Congress
Innate Immune Signaling During Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation.
R. Sosa,¹ A. Zarrinpar,² C. Lassman,¹ R. Busuttil,² D. Gjertson,¹ J. Kupiec-Weglinski,¹ E. Reed.¹
¹Pathology and Lab Medicine, University of California-Los Angeles, Los Angeles, CA; ²Surgery, University of California-Los Angeles, Los Angeles, CA.
Background: Orthotopic liver transplantation (OLT) success is hampered by cellular damage elicited by ischemia-reperfusion injury (IRI) which lowers allograft survival. Research using murine models has…
2016 American Transplant Congress
Successful Prophylactic Use of Eculizumab in aHUS Kidney Transplant Patients: A Report of 9 Cases.
A. Kumar,¹ Z. Stewart,³ A. Reed,³ D. Orozco,² R. Smith,^1,2 C. Nester,^1,2 C. Thomas.^1,2
¹Internal Medicine, Univ of Iowa, Iowa City; ²Pediatrics, Univ of Iowa, Iowa City; ³Surgery, Univ of Iowa, Iowa City.
AHUS is a thrombotic microangiopathy (TMA) triggered by alternate complement pathway (AP) dysregulation. In 60% of patients, a pathogenic variant can be identified in one…
2016 American Transplant Congress
Should HLA DR and DQ Eplet Mismatching Replace Traditional DR and DQ Mismatching for Deceased Donor Offers in Pediatric Renal Transplantation?
C. Bryan, V. Chadha, B. Warady.
Midwest Transplant Network, Kansas City, KS; Nephrology, Childrens Mercy Hospital, Kansas City, MO; Nephrology, Childrens Mercy Hospital, Kansas City, MO.
Introduction. It is now appreciated that greater HLA DR mismatching of the first pediatric kidney transplantation is associated with higher degrees of sensitization, lower rates…
2016 American Transplant Congress
Influence of Donor and Recipient CYP3A4, CYP3A5 and ABCB1 Genotypes on Outcomes in Liver Transplants.
M. Debette-Gratien,¹ J. Woillard,² N. Picard,² M. Sebbagh,⁴ D. Sautereau,⁵ V. Loustaud-Ratti,¹ D. Samuel,³ P. Marquet.²
¹Hepatology, INSERM UMR 850, Univ Limoges, CHU Limoges, Limoges, France; ²Pharmacology and Toxicology, INSERM UMR 850, Univ Limoges, CHU Limoges, Limoges, France; ³Hepatology, INSERM U785, Centre hépatobiliaire, Villejuif, France; ⁴Hepatology, Centre Hépatobiliaire, Villejuif, France; ⁵Hepatology, CHU Limoges, Limoges, France.
Liver transplantation is a life-saving technique for patients with end-stage liver disease. Pharmacogenetics is promising to explain a part of variability of calcineurin inhibitors efficacy…
2016 American Transplant Congress
Optimal Integration of Kidney Exchange Programs with Antibody Reduction Therapy to Increase Successful Transplant in Difficult to Match Recipients.
K. Melancon,¹ N. Koizumi,² M. Gentili,³ C. Callender.⁴
¹Surgery, George Washington University Hospital, Washington, DC; ²Public Policy, George Mason Univ, Arlington, VA; ³Operations Research, University of Louisville, Louisville, KY; ⁴Surgery, Howard University Hospital, Washington, DC.
Kidney paired donation (KPD) allows incompatible pairs to exchange kidneys with other incompatible pairs. However, evidence suggests there stills exist barriers to KPD utilization, especially…
2016 American Transplant Congress
Long-Term Outcomes in Pediatric Live-Donor Liver Transplantation.
N. Celik,¹ A. Ganoza,² F. Vyas,¹ J. Squires,³ V. Venkat,³ G. Bond,¹ K. Soltys,¹ R. Sindhi,¹ R. Squires,³ A. Humar,² G. Mazariegos.¹
¹Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA; ²Thomas E. Starzl Transplantation Institute, Department of Surgery at UPMC, Pittsburgh, PA; ³Division of Pediatric Gastroenterology, CHP of UPMC, Pittsburgh, PA.
Aim: To determine the incidence of allograft and medical factors characterizing optimal patient outcomes 3 year or more after pediatric live-donor liver transplantation (LDLT). Methods:…
2016 American Transplant Congress
Mass Cytometry Reveals NK Cell and T Cell Subsets in Pediatric Liver Transplant Patients with Acute Rejection.
A. Lau,^1,2 K. Haas,¹ T. Shawler,² C. Esquivel,² O. Martinez,² R. Castillo,¹ S. Krams.²
¹Pediatrics, Stanford/LPCH, Palo Alto, CA; ²Surgery, Stanford, Palo Alto, CA.
Proper evaluation of the immune status of liver transplant recipients is crucial for appropriate post-transplant management. Current monitoring of graft function relies mainly on non-specific…
2016 American Transplant Congress
Evaluation of Polyomavirus (BK) Treatment and Clinical Outcomes in Pediatric Kidney Transplant Recipients: A >10 Year Single Center Retrospective Experience.
R. Liverman,¹ E. Kraus,¹ R. Garro,² B. Warshaw,² P. Winterberg,² R. George.²
¹Children's Healthcare of Atlanta, Atlanta, GA; ²Division of Pediatric Nephrology, Emory University School of Medicine, Atlanta, GA.
BK viremia (BKV) is a serious infectious complication after kidney transplantation and can lead to BK nephropathy (BKN) and allograft loss. We reviewed our experience…
2016 American Transplant Congress
Urinary Tract Infections During the First Year After Renal Transplantation: Risk Factors and Nomograms.
C. Jironda, V. López, M. Cabello, A. Duarte, C. Gutiérrez, P. Ruiz, D. Burgos, D. Hernández.
Nephrology, Regional University Hospital, Málaga, Spain.
Background: Urinary tracts infections (UTIs) are the most common infectious complications following renal transplantation (RT). The aim of this study was to evaluate the frequency…
2016 American Transplant Congress
Marked Alterations in Gene Expression in Peripheral Blood Leukocytes of Kidney Transplant (tx) Recipients Following Mycophenolic Acid (MPA) Treatment.
K. Sanghavi,¹ B. Wu,¹ C. Dorr,² A. Muthuswamy,² W. Guan,¹ D. Schladt,² R. Remmel,¹ D. Ilke,³ A. Matas,¹ A. Israni,² W. Oetting,¹ P. Jacobson.¹
¹University of Minnestoa, Minneapolis; ²MMRC, Hennepin County Medical Center, Minneapolis; ³Rho.
MPA exerts its immunosuppressive activity by inhibiting IMPDH2 enzyme, halting DNA synthesis in T and B lymphocytes. Cell culture models have shown MPA effects on…